Introduction Studies investigating histologic follow-up of The 2001 Bethesda System
diagnosis of atypical glandular cells (AGC) have focused on various screening methods …

Abstract BACKGROUND The 2001 Bethesda System recommended qualification of atypical
glandular cells (AGC) to indicate the site of origin and separated endocervical …

OBJECTIVE: We sought to estimate the rates and types of evaluation in women with atypical
glandular cells of undetermined significance (AGC-US) on cervical cytology and to assess …

Objectives: We sought to determine the follow-up rate of women with glandular atypia on
routine Papanicolaou smears in a community-based population and to describe the …

Background: To evaluate the histopathology and the long-term follow-up outcome of women
who had atypical glandular cells on Pap smears. Materials and Methods: All women with …

Objective: To determine the prevalence and the rate of clinically significant lesions in women
with atypical glandular cells in cervical Papanicolaou smears. Material and Method: A …

Background Diagnosing atypical glandular cells (AGC) is a significant challenge in
cytomorphology. Methods A retrospective study was undertaken to assess the prevalence of …

Objective: To determine the clinical significance of and underlying pathology among patients
with atypical glandular cells of undetermined significance (AGCUS) identified on cervical …

Background. Atypical glandular cells (AGC) identified on Pap tests may be markers for
potentially significant pathology. Objectives. Primarily, to correlate AGC findings at Groote …

Objective To evaluate the histologic correlation and clinical significance of atypical glandular
cells (AGC) detected on Pap tests. Methods Pap tests interpreted as AGC were retrieved …